title: Current therapeutic apheresis technologies for inflammatory bowel disease.
abstract: A large number of physicians have indicated that patients with inflammatory bowel diseases (IBD) such as ulcerative colitis (UC) and Crohn's disease (CD) respond to current apheresis technology treatment. However, the mechanism of the apheresis procedure is undefined for patients with IBD. IBD appears to be caused by a complex of interactions from the genes, environment, and the immune system; therefore, the immune system plays a crucial role in the inflammatory responses. In this process, lots of interactions occur simultaneously, and they cross relate with each other. This review paper briefly discusses the etiology and pathogenesis of IBD and attempts to elucidate the mechanism that occurs after apheresis treatment.
authors.affiliation: Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA.
authors.forename: K
authors.initials: K
authors.lastname: Yamaji
authors.forename: K
authors.initials: K
authors.lastname: Fukunaga
authors.forename: S
authors.initials: S
authors.lastname: Yamane
authors.forename: A
authors.initials: A
authors.lastname: Sueoka
authors.forename: Y
authors.initials: Y
authors.lastname: Nosé
mesh_terms: D001781:Blood Component Removal / Q000379:methods*; D003093:Colitis, Ulcerative / Q000628:therapy*; D003424:Crohn Disease / Q000628:therapy*; D006801:Humans